FBN1 and type 2 diabetes mellitus: Asprosin is a recently identified adipokine, produced mainly by white adipose tissue (4), implicated in the pathophysiology of several conditions, such as obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and cardiovascular diseases, by preclinical and clinical studies (5, 6).